Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Diabetes
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Diabetes
    Darbepoetin Alfa Risks Outweigh Benefits for Patients With CKD, Diabetes, and Anaemia: Presented at Renal Week 2009 - (DGDispatch)
    Fenofibrate May Protect Diabetics Against Loss of Renal Function: Presented at Renal Week 2009 - (DGDispatch)
    A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease - (N Engl J Med)
    TopAbstracts in Diabetes 11/03/2009 - (DGNews)
    Paricalcitol Added to Hypertension Therapy Lowers Albuminuria in Patients With Diabetes and Chronic Kidney Disease: Presented at Renal Week 2009 - (DGDispatch)

    News archive

     Recent webcasts/CME - Diabetes
    • Optimizing Insulin-Dependent Diabetes Management in Long-Term Care
    • Insulin-Dependent Diabetes in Long-Term Care: Scope of the Problem and Effective Management
    • Cases in Practice: Incretin-Based Therapies for Common Patient Encounters
      Diabetes Management - Pearls of Lipid Control
      Obesity Management in Patients with Type 2 Diabetes

      Webcasts/CME archive

       Recent cases - Diabetes
        Acquired Perforating Dermatosis: Association with Diabetes and Renal Failure
        A Patient Presenting with Symptomatic Hypomagnesemia Caused by Metformin-Induced Diarrhoea: A Case Report
        Absence of Diabetic Retinopathy in a Patient who has had Diabetes Mellitus for 69 Years, and Inadequate Glycemic Control: Case Report
        Gallbladder Edema in Type 1 Diabetic Patient due to Delayed-type Insulin Allergy
        Compound Heterozygous Mutation of Aquaporin 2 Gene in Woman Patient with Congenital Nephrogenic Diabetes Insipidus

        Cases archive
          




        my personal edition > diabetes > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Aetiology More Than Wound Size Determines Healing Time For Diabetic Foot Ulcers

        A DGReview of :"Determinants and estimation of healing times in diabetic foot ulcers"
        Journal of Diabetes and its Complications

        10/09/2002
        By Andrew A. Skolnick


        Wound healing times are better determined by aetiologic factors than by wound size in standard care for diabetic foot ulcers.

        In a prospective study of patients with type 1 or type 2 diabetes, Dr. Stefan Zimny and colleagues at the Ruhr-Universitat Bochum, in Bochum, Germany, assessed wound healing times of plantar foot ulcers.

        Thirteen consecutive diabetic patients with neuropathic foot ulceration, 10 diabetic patients with neuroischaemic ulceration, and eight diabetic patients with peripheral occlusive vascular disease were selected for the study.

        All patients received identical ulcer wound care, including use of proper footwear, non-weight-bearing limb support, use of appropriate antibiotics, debridement, tight control of serum glucose levels, and careful monitoring of the ulcer, the investigators noted.

        Ulcer healing was assessed by planimetric measurement of the wound area every second week until wound healing. The time course of wound healing was calculated by the daily wound radius reduction.

        The mean wound area in patients with neuropathic foot ulceration was 61.2 ± 17.1 mm˛ at the beginning, and 3.2 ± 1.5 mm˛ after 70 days. The wound radius decreased by 0.045 mm per day, with most of the wound healing occurring between the first and seventh week of ulcer care. The average healing time was 77.7 days, the researchers reported.

        In the neuroischaemic group, the initial average wound area was 26.6 ± 7.0 mm˛ and 6.25 ± 1.7 mm˛ after 10 weeks. The wound radius reduction was 0.019 mm per day, with an average healing time of 123.4 days.

        Diabetic patients with peripheral occlusive vascular disease had an average wound size of 32.6 ± 13.1 mm˛ at the beginning and 23.9 ± 10.7 mm˛ after 70 days. The daily wound radius reduction was 0.0065 mm. Average ulcer duration was 133 days, although three of eight patients achieved no wound healing, the investigators reported.

        "Providing standard care, the time course of wound healing in diabetic foot ulcers is predominantly determined by aetiologic factors, and less by wound size," they concluded. "Taking wound aetiology and wound radius into account, the expected healing time can reliably be estimated in neuropathic and neuroischaemic ulcers."
        J Diabetes Complications 2002; 16: 327-332. "Determinants and estimation of healing times in diabetic foot ulcers"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send